forecast pe at 6, page-9

I agree that the PE number is misleading.

However, the historic revenue is even more misleading. The company's main products are ReferralNet and MasterCare, but this is a relatively recent state of affairs.

Global Health in 2005 (or for that matter 2009) was a very different business (one with no recurring revenues to speak of, and high operating costs compared to revenue).

At any rate the high level of uncertainty and low liquidity is likely to keep the share price volatile. Plenty are sitting on massive gains.

We'll see what happens as it plays out. There is definitely a downside, however, I believe the upside far outweighs it. Ultimately, one bit of research that is required is to get in contact with customers, and see if they are satisfied with the product.